Back to Search
DAVID SPALDING, MD
MD
Rheumatology Physician
NPI: 1235114976Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
7366(AL)
Research & Publications (20)
Non-occlusive small bowel necrosis in association with feeding jejunostomy after elective upper gastrointestinal surgery.
PMID 19558785·Ann R Coll Surg Engl·2009
8-other
Pancreas-sparing distal duodenectomy for infrapapillary neoplasms.
PMID 17346405·Ann R Coll Surg Engl·2007
8-other
Pancreatic and periampullary cancers: treatment and outcome.
PMID 16447398·Br J Hosp Med (Lond)·2006
6-review
Duodenal duplication cyst (DDC) communicating with the pancreatobiliary duct--a rare cause of recurrent acute pancreatitis in adults.
PMID 19440800·J Gastrointest Surg·2010
5-case
Impact of chronic inflammation on the pharmacokinetic-pharmacodynamic relationship of naproxen.
PMID 19679500·Eur J Pain·2010
7-preclinical
Percutaneous transhepatic cholecystoduodenal stent for empyema of the gallbladder.
PMID 19451308·Br J Radiol·2009
5-case
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs).
PMID 19467868·Bioorg Med Chem Lett·2009
7-preclinical
Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors.
PMID 18774319·Eur J Pain·2009
7-preclinical
Repeat hepatic resection using a radiofrequency-assisted technique.
PMID 18769067·Dig Surg·2008
8-other
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
PMID 18193075·Br J Pharmacol·2008
7-preclinical
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
PMID 17098427·Bioorg Med Chem Lett·2007
7-preclinical
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
PMID 17175160·Bioorg Med Chem Lett·2007
7-preclinical
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
PMID 17084082·Bioorg Med Chem Lett·2007
7-preclinical
Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers.
PMID 16682968·Br J Pharmacol·2006
7-preclinical
Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.
PMID 16931004·Bioorg Med Chem Lett·2006
7-preclinical
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
PMID 16697196·Bioorg Med Chem Lett·2006
7-preclinical
Discovery of novel biaryl heterocyclic EP1 receptor antagonists.
PMID 16503138·Bioorg Med Chem Lett·2006
7-preclinical
Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.
PMID 16330496·J Pharmacol Exp Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1201 11TH AVE S, SUITE 510
BIRMINGHAM, AL 35205 - Phone
- (205) 930-8347
Quick Facts
- NPI
- 1235114976
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile